Ain Holdings Inc. · TSE:9627
Ain — Q1 FY2027 Earnings Presentation
23 slides from Ain's earnings presentation, Sep 14, 2026
Slide 1: FY2027 1Q IR Presentation
FY2027 1Q IR PRESENTATION September 14, 2026
Slide 2: Results Overview
Results Overview © AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L While the company was affected by factors such as drug price revisions and dispensing fee revisions, net sales increased 33.2% YoY and 1.4% against the plan due to the contribution of the Sakura Pharmacy Group, which joined the group. Operating profit increased 8.4% YoY and decrease
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales increased 39.3% YoY and 2.4% against the plan due to the contribution of Sakura Pharmacy Group and the number of prescriptions has remained steady. Operating profit increased 27.2% YoY and decreased 2.3% against the plan, due to factors such as d
Slide 5: Retail Business (Consolidated)
Retail Business (Consolidated) While the average spending per customer at AINZ & TULPE and Francfranc remained steady, the number of customers fell short of the plan due to weather-related factors—such as temperatures remained lower than the previous year—resulting in net sales up 6.7% YoY and decre
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥(112,360) million due to the repayment of funds used to acquire shares of the Sakura Pharmacy Group, etc. End-FY2026 End-FY2027 1Q (¥ million) (¥ million) Assets Liabilities and Net Assets Assets Liabilities and Net Assets Current Current Current assets 173,173 liab
Slide 7: Assets
Assets The balance of total assets decreased ¥998 million from the end of the fiscal year 2026, mainly reflecting decrease in accounts receivable – trade and the amortization of goodwill. (¥ million) End-FY2026 1Q End-FY2026 End-FY2027 1Q Change Cash and deposits 46,180 50,925 54,265 ＋3,340 Accounts
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets Accounts payable – trade increased ¥4,498 million due to M&A activities and the opening of new stores. Short- term and long-term borrowings decreased ¥5,229 million due to the repayment of funds used to acquire shares of the Sakura Pharmacy Group, etc. (¥ million) End-FY20
Slide 9: Review
Review © AIN HOLDINGS INC. All Rights Reserved. 8
Slide 10: Consolidated (YoY results)
Consolidated (YoY results) Net sales increased ¥44.2 billion, driven by the contribution of the newly acquired Sakura Pharmacy Group, growth at existing stores, and the contribution of new stores opened in the previous fiscal year. On the other hand, operating profit rose by only ¥0.4 billion due to
Slide 11: Consolidated (vs plan)
Consolidated (vs plan) Net sales exceeded the plan by ¥2.5 billion due to steady growth in the number of prescriptions and the average prescription price in the dispensing pharmacy business. On the other hand, operating profit fell short of the plan by ¥0.9 billion, primarily because the retail busi
Slide 12: Number of Pharmacies and Stores
Number of Pharmacies and Stores The number of new stores opened in the dispensing pharmacy business (including M&A) was 14, and the number of new stores opened in the retail business was 6. As of the end of the first quarter of FY2027, the dispensing pharmacy business had 2,143 stores and the retail
Slide 13: Average days of prescription and average prescription value
Average days of prescription and average prescription value The number of prescriptions continues to show a slight downward trend due to the increase in the average days of prescription. On the other hand, the average prescription value is rising due to the increase in the number of prescription day
Slide 14: FY2027 Plan
FY2027 Plan © AIN HOLDINGS INC. All Rights Reserved. 13
Slide 15: FY2027 Plan (Dispensing Pharmacy Business)
FY2027 Plan (Dispensing Pharmacy Business) The group forecasts net sales increase 11.7% YoY and operating profit increase 0.7% YoY, due to the impact of dispensing fee revisions, and an increase in the average prescription price resulting from proper evaluation of technical fees and a rise in high-c
Slide 16: FY2027 Plan (Retail Business)
FY2027 Plan (Retail Business) The group forecasts net sales increase 9.7% YoY and operating profit increase 16.4% YoY due to new store openings and growth in existing stores of AINZ & TULPE and Francfranc. FY2025 FY2026 FY2027 YoY YoY （¥ million） results results plan change change(%) Net sales 61,04
Slide 17: FY4/27 Plan (Consolidated)
FY4/27 Plan (Consolidated) The group forecasts net sales increase 11.4% YoY and operating profit increase 8.9% YoY, due to the growth of new stores in both businesses, the impact of dispensing fee revisions, and the full contribution of Sakura Pharmacy Group. FY2025 FY2026 FY2027 YoY YoY （¥ million）
Slide 18: Appendix
Appendix © AIN HOLDINGS INC. All Rights Reserved. 17
Slide 19: Shareholder return
Shareholder return We have maintained shareholder returns based on progressive dividends, balancing growth investments and shareholder returns. Going forward, while continuing to invest toward our medium-to-long-term vision, we will target a dividend payout ratio of 30.0% as our medium-to-long-term
Slide 20: Digital transformation investments medium-term measures
Digital transformation investments medium-term measures In each business and whole the company, digital transformation measures to expand the scale of business, and the upgrading of operations using IT, etc., are set as mid-term measures by fiscal 2027. The company provides added value that only AIN
Slide 21: Human capital
Human capital We aim to hire about 500 new pharmacists, 300 new medical support staff, and 130 new retail staff and others in fiscal 2027. The employee turnover rate among full-time employees has been declining as a result of efforts in human resource strategy, including changes to the personnel sys
Slide 22: Sustainability management Materiality
Sustainability management Materiality In December 2025, we conducted a review of our materiality in light of the announcement of our medium-to- long-term vision and changes in the external environment. Going forward, by keeping in mind our diverse stakeholders, including our customers, and by proact
Slide 23: AIN HOLDINGS INC. Corporate Planning Division
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL: +81-3-5333-1812 https://www.ainj.co.jp/corporate/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document has been